当前位置:首页 - 行情中心 - 三诺生物(300298) - 财务分析 - 现金流量表

三诺生物

(300298)

  

流通市值:85.34亿  总市值:106.08亿
流通股本:4.48亿   总股本:5.57亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,892,656,133.322,535,440,506.831,203,883,454.764,972,518,406.69
  收到的税费返还64,272,686.5819,897,119.3610,176,373.5737,459,740.74
  收到其他与经营活动有关的现金29,396,471.2417,526,723.3510,217,871.5364,349,868.04
  经营活动现金流入小计3,986,325,291.142,572,864,349.541,224,277,699.865,074,328,015.47
  购买商品、接受劳务支付的现金1,344,597,837.13877,904,287.66470,465,838.631,889,558,168.67
  支付给职工以及为职工支付的现金917,335,635.76651,406,523.24358,767,043.251,212,570,383.93
  支付的各项税费273,491,562.25185,768,871.3773,123,402.55306,526,118.8
  支付其他与经营活动有关的现金984,204,150.77620,294,953.88276,027,125.081,060,528,775.49
  经营活动现金流出小计3,519,629,185.912,335,374,636.151,178,383,409.514,469,183,446.89
  经营活动产生的现金流量净额466,696,105.23237,489,713.3945,894,290.35605,144,568.58
二、投资活动产生的现金流量:
  收回投资收到的现金---34,452,466.02
  取得投资收益收到的现金4,142,033.38832,536.93832,536.931,580,438.22
  处置固定资产、无形资产和其他长期资产收回的现金净额1,429,601.1408,130.6456,363.286,858.7
  收到的其他与投资活动有关的现金610,663,976.92142,482,266.71105,080,067.951,241,291,973.12
  投资活动现金流入小计616,235,611.4143,722,934.28105,968,968.081,277,411,736.06
  购建固定资产、无形资产和其他长期资产支付的现金103,719,950.1672,655,001.7538,764,904.66198,871,579.45
  投资支付的现金3,497,6833,497,6833,297,683-
  取得子公司及其他营业单位支付的现金----122,967.08
  支付其他与投资活动有关的现金949,520,890.96162,776,478.6650,000,0001,372,554,877.35
  投资活动现金流出小计1,056,738,524.12238,929,163.4192,062,587.661,571,303,489.72
  投资活动产生的现金流量净额-440,502,912.72-95,206,229.1313,906,380.42-293,891,753.66
三、筹资活动产生的现金流量:
  取得借款收到的现金274,164,782.97231,341,934.9181,002,288.92421,740,381.86
  收到其他与筹资活动有关的现金---1,089,811.72
  筹资活动现金流入小计274,164,782.97231,341,934.9181,002,288.92422,830,193.58
  偿还债务支付的现金144,652,330.66137,252,330.66113,283,133.48442,567,639.2
  分配股利、利润或偿付利息支付的现金5,071,366.543,100,931.321,181,706.19136,787,579.63
  其中:子公司支付给少数股东的股利、利润---1,679,238.19
  支付其他与筹资活动有关的现金256,800,354.8232,780,014.25102,032,170.11219,185,675.82
  筹资活动现金流出小计406,524,052373,133,276.23216,497,009.78798,540,894.65
  筹资活动产生的现金流量净额-132,359,269.03-141,791,341.32-135,494,720.86-375,710,701.07
四、汇率变动对现金及现金等价物的影响-21,196,486.41-19,938,479.14-8,270,355.53-7,126,733.52
五、现金及现金等价物净增加额-127,362,562.93-19,446,336.2-83,964,405.62-71,584,619.67
  加:期初现金及现金等价物余额770,870,272.55770,878,838.55770,870,272.55842,454,892.22
  期末现金及现金等价物余额643,507,709.62751,432,502.35686,905,866.93770,870,272.55
补充资料:
  净利润-226,680,605.13-22,076,674.05
  资产减值准备-7,162,193.8-195,074,989.94
  固定资产和投资性房地产折旧-60,912,717.24-142,387,334.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-60,912,717.24-142,387,334.51
  无形资产摊销-11,721,001.63-39,286,500.11
  长期待摊费用摊销-1,747,923.85-5,524,808.79
  处置固定资产、无形资产和其他长期资产的损失--292,657.07-1,143,532.66
  固定资产报废损失-34,631.52--
  公允价值变动损失--1,440,428.08--1,345,429.99
  财务费用-18,761,901.38-41,795,122.03
  投资损失--200,291.29--1,401,010.78
  递延所得税-544,441.11--15,704,014.13
  其中:递延所得税资产减少-1,097,152.76--15,170,721.67
    递延所得税负债增加--552,711.65--533,292.46
  存货的减少-23,813,970.48--108,959,165.66
  经营性应收项目的减少--74,433,470.07-92,671,491.6
  经营性应付项目的增加--43,215,155.81-177,132,967.17
  现金的期末余额-751,432,502.35-770,870,272.55
  减:现金的期初余额-770,878,838.55-842,454,892.22
  现金及现金等价物的净增加额--19,446,336.2--71,584,619.67
公告日期2026-10-232026-08-042026-04-282026-04-28
审计意见(境内)标准无保留意见
TOP↑